Otsuka Holdings Co (STU:OS1) Notes Receivable: €0 Mil (As of Mar. 2026)


STU:OS1 Otsuka Holdings Co Ltd STU:OS1
82 GF Score
Price €59.50
GF Value €45.23
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Otsuka Holdings Co Notes Receivable?

Otsuka Holdings Co STU:OS1 +0.85% 82 Notes Receivable is €0 Mil as of Mar. 2026. GuruFocus rates STU:OS1 with a GF Score™ of 82/100 and a GF Value™ of €45.23 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Otsuka Holdings Co's Notes Receivable for the quarter that ended in Mar. 2026 was €0 Mil.

Otsuka Holdings Co Notes Receivable Related Terms

Otsuka Holdings Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for Otsuka Holdings Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otsuka Holdings Co Notes Receivable Chart

Otsuka Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Otsuka Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:OS1
82GF Score
Otsuka Holdings Co Ltd STU:OS1
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otsuka Holdings Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0 Mil mean?
Otsuka Holdings Co (STU:OS1) has a Notes Receivable of €0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Otsuka Holdings Co and its competitors.
Is Otsuka Holdings Co's Notes Receivable too high?
Otsuka Holdings Co's current Notes Receivable is €0 Mil. Overall, Otsuka Holdings Co has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's Notes Receivable compare to LLY and JNJ?
Otsuka Holdings Co's Notes Receivable of €0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Otsuka Holdings Co and its competitors. Otsuka Holdings Co's current Notes Receivable is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (STU:OS1) is currently considered Significantly Overvalued. The stock's GF Value™ is €45.23, compared to a current price of €59.50 — trading 31.5% above its estimated fair value. The current Notes Receivable is €0 Mil. Otsuka Holdings Co's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Otsuka Holdings Co (STU:OS1), the current Notes Receivable is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Otsuka Holdings Co (STU:OS1) Overvalued in 2026?

Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued. The current stock price of €59.50 is trading 31.5% above its estimated GF Value™ of €45.23. GuruFocus considers Otsuka Holdings Co to be Significantly Overvalued.

Key valuation signals for STU:OS1:

  • Notes Receivable: €0 Mil
  • GF Value™: €45.23 vs. price of €59.50 (31.5% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the STU:OS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Otsuka Holdings Co Business Description

Address 2-16-4 Konan, Shinagawa Grand Central Tower, Minato-ku, Tokyo, JPN, 108-8241
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
82GF Score

Get the complete analysis for STU:OS1

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€59.50
Price
€45.23
GF Value